Welcome to LookChem.com Sign In|Join Free
  • or
LOBEGLITAZONE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

607723-33-1

Post Buying Request

607723-33-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

607723-33-1 Usage

Uses

Lobeglitazone is used in anti-diabetes mellitus pharmacological management.

Check Digit Verification of cas no

The CAS Registry Mumber 607723-33-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,7,7,2 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 607723-33:
(8*6)+(7*0)+(6*7)+(5*7)+(4*2)+(3*3)+(2*3)+(1*3)=151
151 % 10 = 1
So 607723-33-1 is a valid CAS Registry Number.

607723-33-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (5R)-5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

1.2 Other means of identification

Product number -
Other names UNII-MY89F08K5D

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:607723-33-1 SDS

607723-33-1Downstream Products

607723-33-1Relevant academic research and scientific papers

Process development and scale-up of PPAR α/γ Dual agonist lobeglitazone sulfate (CKD-501)

Lee, Hong Woo,Ahn, Joong Bok,Kang, Sung Kwon,Ahn, Soon Kil,Ha, Deok-Chan

, p. 190 - 199 (2007)

A scaleable synthetic route to the potent PPARα/γ dual agonistic agent, lobeglitazone (1), used for the treatment of type-2 diabetes was developed. The synthetic pathway comprises an effective five-step synthesis. This process involves a consecutive synth

Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione

Lee, Hong Woo,Bok, Young Kim,Joong, Bok Ahn,Sung, Kwon Kang,Lee, Jung Hwa,Jae, Soo Shin,Soon, Kil Ahn,Lee, Sang Joon,Seung, Soo Yoon

, p. 862 - 874 (2007/10/03)

We previously reported the synthesis and biological activity of novel substituted pyridines and purines having thiazolidinedione with hypoglycemic and hypolipidemic activities. We now report the synthesis and antidiabetic activity of novel substituted pyr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 607723-33-1